• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bretylium tosylate in the management of refractory ventricular fibrillation.溴苄铵托西酸盐用于难治性心室颤动的治疗
Can Med Assoc J. 1971 Jul 24;105(2):161-5 passim.
2
Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.甲苯磺酸溴苄铵用于治疗急性心肌梗死并发的复发性心室颤动。
Heart Lung. 1980 Mar-Apr;9(2):265-70.
3
Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction.急性心肌梗死原发性心室颤动预防的综合治疗方案
Am J Cardiol. 1974 May 6;33(5):661-7. doi: 10.1016/0002-9149(74)90259-8.
4
Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction.甲苯磺丁胺治疗心肌梗死并发的难治性室性心律失常。
Br Heart J. 1970 Jan;32(1):21-5. doi: 10.1136/hrt.32.1.21.
5
Chemical ventricular defibrillation of the human heart with bretylium tosylate.用溴苄铵进行人体心脏的化学性心室除颤。
Am J Cardiol. 1973 Dec;32(7):982-7. doi: 10.1016/s0002-9149(73)80168-7.
6
Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
J Pharmacol. 1986 Jul-Sep;17(3):223-43.
7
Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.用溴苄铵治疗心室颤动及其他急性心律失常。
Am J Cardiol. 1968 Apr;21(4):530-43. doi: 10.1016/0002-9149(68)90286-5.
8
Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block.甲苯磺酸溴苄铵对心室颤动、心律失常和心脏传导阻滞的实验及临床效应。
Geriatrics. 1971 Jan;26(1):132-48.
9
Management of ventricular dysrhythmias in the prehospital and emergency department setting.院前及急诊科环境下心室性心律失常的管理。
Am J Cardiol. 1984 Jul 30;54(2):34A-36A. doi: 10.1016/0002-9149(84)90815-4.
10
[Bretylium tosylate in the treatment and prevention of ventricular arrhythmia: a new look at an old drug].
Pol Tyg Lek. 1988 Oct 31;43(44):1415-8.

引用本文的文献

1
Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.心脏急症药物治疗中的药代动力学和药效学考量
Clin Pharmacokinet. 1984 Jul-Aug;9(4):273-308. doi: 10.2165/00003088-198409040-00001.
2
Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.钾通道阻滞:一种抑制心室颤动的机制。
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2223-7. doi: 10.1073/pnas.83.7.2223.
3
Bretylium and dobutamine in the treatment of coronary artery disease.溴苄铵和多巴酚丁胺治疗冠状动脉疾病
Bull N Y Acad Med. 1979 Sep;55(8):798-809.

本文引用的文献

1
The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records.从细胞内电位记录解读奎尼丁对离体兔心房的作用方式。
Br J Pharmacol Chemother. 1958 Sep;13(3):276-87. doi: 10.1111/j.1476-5381.1958.tb00903.x.
2
Bretylium tosylate for suppression of induced ventricular fibrillation.甲苯磺酸溴苄铵用于抑制诱发性心室颤动。
Am J Cardiol. 1966 Apr;17(4):528-34. doi: 10.1016/0002-9149(66)90244-x.
3
The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity.溴苄铵对细胞内心脏动作电位的影响及其抗心律失常和局部麻醉活性的关系。
Br J Pharmacol. 1969 Oct;37(2):380-90.
4
The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.抗心律失常药物的临床药理学及治疗应用。
Clin Pharmacol Ther. 1970 Jul-Aug;11(4):460-80. doi: 10.1002/cpt1970114460.
5
Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction.甲苯磺酸溴苄铵预防心肌梗死后心律失常
Br Heart J. 1970 May;32(3):326-9. doi: 10.1136/hrt.32.3.326.
6
Ventricular fibrillation complicating acute myocardial infarction.急性心肌梗死并发心室颤动。
Lancet. 1968 Sep 7;2(7567):523-8. doi: 10.1016/s0140-6736(68)92403-3.
7
A mobile intensive-care unit in the management of myocardial infarction.移动重症监护单元在心肌梗死管理中的应用
Lancet. 1967 Aug 5;2(7510):271-3. doi: 10.1016/s0140-6736(67)90110-9.

溴苄铵托西酸盐用于难治性心室颤动的治疗

Bretylium tosylate in the management of refractory ventricular fibrillation.

作者信息

Dhurandhar R W, Teasdale S J, Mahon W A

出版信息

Can Med Assoc J. 1971 Jul 24;105(2):161-5 passim.

PMID:5556280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1930955/
Abstract

Nine patients who had recurrent ventricular fibrillation following acute myocardial infarction or angina were given bretylium tosylate in a dose of 5 mg./kg. intramuscularly every eight hours after other measures had proved ineffective. Provided the patients were not in shock or in heart failure, there was a considerable reduction in the episodes of ventricular fibrillation.A second group of nine patients who developed recurrent ventricular fibrillation following open heart surgery were given bretylium intravenously, which controlled the arrhythmia in every instance.Bretylium did not completely abolish ventricular premature beats but the latter did not initiate ventricular fibrillation even when they occurred on the T wave.

摘要

9例急性心肌梗死或心绞痛后发生反复心室颤动的患者,在其他措施均无效后,每8小时给予5mg/kg的甲苯磺酸溴苄铵肌肉注射。只要患者没有休克或心力衰竭,心室颤动的发作次数就会显著减少。第二组9例心脏直视手术后发生反复心室颤动的患者接受了静脉注射甲苯磺酸溴苄铵,均控制了心律失常。溴苄铵并没有完全消除室性早搏,但即使室性早搏出现在T波上,也不会引发心室颤动。